JP2007504168A5 - - Google Patents

Download PDF

Info

Publication number
JP2007504168A5
JP2007504168A5 JP2006524941A JP2006524941A JP2007504168A5 JP 2007504168 A5 JP2007504168 A5 JP 2007504168A5 JP 2006524941 A JP2006524941 A JP 2006524941A JP 2006524941 A JP2006524941 A JP 2006524941A JP 2007504168 A5 JP2007504168 A5 JP 2007504168A5
Authority
JP
Japan
Prior art keywords
compound
composition
amount
use according
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006524941A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504168A (ja
JP4846581B2 (ja
Filing date
Publication date
Priority claimed from US10/652,813 external-priority patent/US7087790B2/en
Application filed filed Critical
Publication of JP2007504168A publication Critical patent/JP2007504168A/ja
Publication of JP2007504168A5 publication Critical patent/JP2007504168A5/ja
Application granted granted Critical
Publication of JP4846581B2 publication Critical patent/JP4846581B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006524941A 2003-08-29 2004-08-30 ベンゾトロポロン誘導体および炎症反応の緩和 Expired - Fee Related JP4846581B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/652,813 2003-08-29
US10/652,813 US7087790B2 (en) 2003-08-29 2003-08-29 Benzotropolone derivatives and modulation of inflammatory response
PCT/US2004/028164 WO2005021479A1 (en) 2003-08-29 2004-08-30 Benzotropolone derivatives and modulation of inflammatory response

Publications (3)

Publication Number Publication Date
JP2007504168A JP2007504168A (ja) 2007-03-01
JP2007504168A5 true JP2007504168A5 (enExample) 2007-10-11
JP4846581B2 JP4846581B2 (ja) 2011-12-28

Family

ID=34217746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524941A Expired - Fee Related JP4846581B2 (ja) 2003-08-29 2004-08-30 ベンゾトロポロン誘導体および炎症反応の緩和

Country Status (6)

Country Link
US (2) US7087790B2 (enExample)
EP (1) EP1663931B1 (enExample)
JP (1) JP4846581B2 (enExample)
CN (1) CN1852881B (enExample)
CA (1) CA2536842C (enExample)
WO (1) WO2005021479A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087790B2 (en) * 2003-08-29 2006-08-08 Rutgers, The State University Of New Jersey Benzotropolone derivatives and modulation of inflammatory response
EP1883416A4 (en) * 2005-05-24 2013-06-12 Wellgen Inc COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CONDITIONS RELATED TO INFLAMMATION
WO2008019985A1 (en) * 2006-08-14 2008-02-21 Unilever Plc Method of purifying theaflavins
WO2009117145A1 (en) 2008-03-21 2009-09-24 Rutgers, The State University Of New Jersey Use of tea-derived, theaflavin enriched extract to increase exercise performance and reduce exercise recovery time
CN102238983B (zh) * 2008-06-25 2016-08-24 巴斯夫欧洲公司 苯并环庚三烯酚酮衍生物作为uv吸收剂和抗氧化剂的用途及其在防晒剂和/或化妆品组合物中的用途
RU2396244C1 (ru) * 2008-12-23 2010-08-10 Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) Способ получения пурпурогаллина
JP5694149B2 (ja) 2009-05-21 2015-04-01 サントリーホールディングス株式会社 ベンゾトロポロン環含有化合物を含む抗肥満剤
BR112012007685B1 (pt) * 2009-10-06 2024-03-05 Basf Se Uso de derivados de benzotropolona
US20110082198A1 (en) * 2009-10-07 2011-04-07 Jiangsu Dehe Bio-Tech Co., Ltd. Theaflavin compositions, production, and methods to control physiological disorders in mammals
US8282970B2 (en) * 2009-10-07 2012-10-09 Jiahgsu Dehe Bio-Tech Co., Ltd Theaflavin compositions, related processes and methods of use
JP5424424B2 (ja) * 2011-10-03 2014-02-26 国立大学法人 鹿児島大学 抗炎症剤または抗炎症作用を有する飲食品
WO2014022287A1 (en) * 2012-07-29 2014-02-06 The Regents Of The University Of Colorado, A Body Corporate Antagonists of the toll-like receptor 1/2 complex
JP2014148530A (ja) * 2014-04-21 2014-08-21 Amazonia Fitomedicamentos Ltda ラノスタ−8,24−ジエン−3−オールの薬学的使用
JP6628970B2 (ja) * 2015-03-09 2020-01-15 サントリーホールディングス株式会社 ベンゾトロポロン環含有化合物を定量する方法
EP3370523A4 (en) 2015-11-04 2019-12-18 The Penn State Research Foundation CONNECTIONS, COMPOSITIONS AND METHOD FOR COLORING EDIBLE MATERIALS
US10738002B2 (en) 2016-11-24 2020-08-11 Universitair Ziekenhuis Antwerpen Halogenated benzotropolones as ATG4B inhibitors
WO2020018474A2 (en) 2018-07-16 2020-01-23 Ziegler Gregory Ray Compounds, compositions, and methods for coloring edible materials
CN114869878B (zh) * 2022-04-08 2024-02-23 南通大学 表儿茶素没食子酸酯在制备治疗高原脑水肿药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812266A (en) * 1972-01-31 1974-05-21 Lipton T Inc Green tea conversion using tannase and natural tea enzymes
TW381092B (en) * 1995-07-07 2000-02-01 Otsuka Pharma Co Ltd Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
US6469053B1 (en) * 1996-04-02 2002-10-22 Mars Incorporated Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
US5861415A (en) * 1996-07-12 1999-01-19 Sami Chemicals & Extracts, Ltd. Bioprotectant composition, method of use and extraction process of curcuminoids
DE69802046T2 (de) * 1997-07-15 2002-03-14 Unilever N.V., Rotterdam Verbesserungen bezüglich auf Theaflavin Erzeugung
GB9902777D0 (en) * 1999-02-08 1999-03-31 Unilever Plc Cold water infusing leaf tea
EP1214040A4 (en) 1999-09-21 2004-06-23 Univ Rutgers USE OF ORANGE SKIN EXTRACTS IN THE PREVENTION AND TREATMENT OF CANCER
US6348224B1 (en) * 2000-03-16 2002-02-19 Lipton, Division Of Conopco, Inc. Black tea manufacture
AU2001261004B2 (en) * 2000-03-22 2006-07-13 Mars, Incorporated The use of cocoa procyanidins combined with acetylsalicyclic acid as an anti-platelet therapy
JP3694733B2 (ja) * 2000-06-29 2005-09-14 独立行政法人農業・生物系特定産業技術研究機構 抗アレルギー剤
US7087790B2 (en) 2003-08-29 2006-08-08 Rutgers, The State University Of New Jersey Benzotropolone derivatives and modulation of inflammatory response

Similar Documents

Publication Publication Date Title
JP2007504168A5 (enExample)
JP2009533356A5 (enExample)
EP4566601A3 (en) Methods for improving mitophagy in subjects
EP2112151A3 (en) Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
JP2010077141A5 (enExample)
MX338247B (es) Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos.
EP4553071A3 (en) Methods for improving mitophagy in subjects
JP2015505564A5 (enExample)
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2023116697A5 (enExample)
FI3164125T3 (fi) Menetelmiä ja koostumuksia liikalihavuuden hoitamiseksi, painonnousun ehkäisemiseksi, painonpudotuksen edistämiseksi, laihtumisen edistämiseksi tai diabeteksen hoitamiseksi tai sen kehittymisen ehkäisemiseksi
JP6063550B2 (ja) 薬物誘発性手足症候群を治療するための組成物および方法
FI4349369T3 (fi) Lääkkeen biologisen hyötyosuuden lisääminen naltreksonihoidossa
JP2011510922A5 (enExample)
JP2016531885A5 (enExample)
JP2010138170A (ja) 抗疲労組成物
JP2012511510A5 (enExample)
JP2017514858A5 (enExample)
JP2010500284A5 (enExample)
WO2007145863A3 (en) Sustained release formulation of naltrexone
WO2007023154A3 (de) EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG
JP2008533021A5 (enExample)
ES2525931T3 (es) Composiciones y métodos para prevenir o tratar enfermedad inflamatoria intestinal
MX2010013978A (es) Derivados de 5-(4-metanosulfonilfenil)tiazol para el tratamiento de enfermedades inflamatorias agudas y cronicas.